Global Home Infusion Therapy Market Report (2022-2027): Continuing Improvements and Technological Advancements in Home Infusion Therapy Current Opportunities –

DUBLIN–(BUSINESS WIRE)–The report “Global Home Infusion Therapy Market (2022-2027) by Products, Indication & Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” has been added to offer.

The global home infusion therapy market is estimated to be worth USD 35.1 billion in 2022 and to reach USD 51.81 billion in 2027, growing at a CAGR of 8.1%

market dynamics


  • Growing prevalence of chronic diseases

  • Growing Geriatric Population and the Presence of Health Facilities

  • Growing demand for intravenous drug infusion therapy for home care


  • Lack of reimbursement for home infusion therapy


  • Continuous improvements and technological advances in home infusion therapy

  • Acceleration of Investments in Research and Development Activities


  • Limited Availability of Qualified Professionals

market segmentations

The global home infusion therapy market is segmented on the basis of product, indication and geography.

  • By products, the market is classified into Infusion Pumps, IV Sets, IV Cannulas, and Needleless Connectors.

  • By Indication, the market is classified into Anti-Infectives, Chemotherapy, Enteral Nutrition, Therapeutic Hydration, Immunoglobulin Therapy, Total Parenteral Nutrition and Others.

  • By geography, the market is classified into the Americas, Europe, Middle East and Africa, and Asia Pacific.

company profiles

The report provides a detailed analysis of competitors in the market. Covers financial performance analysis for publicly traded companies in the market. The report also offers detailed information about the recent development and competitive landscape of the companies. Some of the companies covered in this report are B. Braun Melsungen Ag, Baxter International Inc., Becton, Dickinson and Company, Coram LLC, CVS Health Corp., Eli Lilly and Company, Fresenius Kabi AB, ICU Medical Inc., Interim HealthCare Inc. , etc

Countries studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of the Americas)

  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, UAE, Rest of MEA)

  • Asia Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia Pacific)

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool for analyzing and evaluating the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors to categorize players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc.

Ansoff Analysis

The report features an in-depth analysis of the Ansoff matrix for the global home infusion therapy market. The Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to outline strategies for the company’s growth. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is ​​also used for risk analysis to understand the risk involved in each approach.

The analyst analyzes the global home infusion therapy market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has come up with suitable strategies for market growth.

Main topics covered:

1 Report description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Home Infusion Therapy Market by Product

7 Global Home Infusion Therapy Market by Indication

8 Americas Home Infusion Therapy Market

9 Europe Home Infusion Therapy Market

10 Home Infusion Therapy Market in the Middle East and Africa

11 APAC Home Infusion Therapy Market

12 Competitive Scenario

13 company profiles

14 Appendix

Mentioned Companies

  • B. Braun Melsungen Ag

  • Baxter International, Inc.

  • Becton, Dickinson and Company

  • Coram, LLC

  • CVS Health Corp.

  • Eli Lilly and Company

  • Fresenius Kabi AB

  • ICU Medical, Inc.

  • Interim HealthCare, Inc.

  • JMS Co., Ltd.

  • KKR & Co. Inc.

  • McKesson Corp.

  • Nipro Corp.

  • Option Care, Inc.

  • Optum, Inc.

  • PruittHealth Corp.

  • Smiths Medical, PLC

  • Soleo Health Holdings, Inc.

  • Terumo Corp.

For more information on this report, please visit

Global Home Infusion Therapy Market Report (2022-2027): Continuing Improvements and Technological Advancements in Home Infusion Therapy Current Opportunities –

Leave a Reply

Your email address will not be published.

Scroll to top